{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:48:57Z","timestamp":1770886137357,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T00:00:00Z","timestamp":1552089600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Osteoporos"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1007\/s11657-019-0585-2","type":"journal-article","created":{"date-parts":[[2019,3,9]],"date-time":"2019-03-09T03:03:31Z","timestamp":1552100611000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Revised FRAX\u00ae-based intervention thresholds for the management of osteoporosis among postmenopausal women in Sri Lanka"],"prefix":"10.1007","volume":"14","author":[{"given":"Sarath","family":"Lekamwasam","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manju","family":"Chandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sewwandi","family":"Subasinghe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,9]]},"reference":[{"key":"585_CR1","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.jocd.2017.06.022","volume":"20","author":"JA Kanis","year":"2017","unstructured":"Kanis JA, Harvey NC, Johansson H, Oden A, Leslie WD, McCloskey EV (2017) FRAX update. J Clin Densitom 20:360\u2013367","journal-title":"J Clin Densitom"},{"key":"585_CR2","first-page":"554","volume":"24","author":"J Compston","year":"2012","unstructured":"Compston J, Cooper C, McCloskey E, Kanis JA (2012) FRAX updates 2012. Osteoporos Int 24:554\u2013560","journal-title":"Osteoporos Int"},{"key":"585_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1097\/BOR.0000000000000304","volume":"28","author":"EV McCloskey","year":"2016","unstructured":"McCloskey EV, Harvey NC, Johansson H, Kanis JA (2016) FRAX updates 2016. Curr Opin Rheumatol 28:433\u2013441","journal-title":"Curr Opin Rheumatol"},{"key":"585_CR4","doi-asserted-by":"publisher","first-page":"2579","DOI":"10.1007\/s00198-011-1869-6","volume":"23","author":"K Lippuner","year":"2012","unstructured":"Lippuner K, Johansson H, Borgstrom F, Kanis JA, Rizzoli R (2012) Cost-effective intervention thresholds against osteoporotic fractures based on FRAX(R) in Switzerland. Osteoporos Int 23:2579\u20132589","journal-title":"Osteoporos Int"},{"key":"585_CR5","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1007\/s00198-015-3173-3","volume":"26","author":"NC Harvey","year":"2015","unstructured":"Harvey NC, Kanis JA, Oden A, Burge RT, Mitlak BH, Johansson H, McCloskey EV (2015) FRAX and the effect of teriparatide on vertebral and non-vertebral fracture. Osteoporos Int 26:2677\u20132684","journal-title":"Osteoporos Int"},{"key":"585_CR6","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1177\/0272989X16662242","volume":"37","author":"M Paulden","year":"2017","unstructured":"Paulden M, O\u2019Mahony J, McCabe C (2017) Determinants of change in the cost-effectiveness threshold. Med Decis Mak 37:264\u2013276","journal-title":"Med Decis Mak"},{"key":"585_CR7","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1007\/s00198-013-2553-9","volume":"25","author":"E Cheung","year":"2014","unstructured":"Cheung E, Cheung CL, Kung AW, Tan KC (2014) Possible FRAX-based intervention thresholds for a cohort of Chinese postmenopausal women. Osteoporos Int 25:1017\u20131023","journal-title":"Osteoporos Int"},{"key":"585_CR8","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1007\/s11657-013-0148-x","volume":"8","author":"S Lekamwasam","year":"2013","unstructured":"Lekamwasam S (2013) Sri Lankan FRAX model and country-specific intervention thresholds. Arch Osteoporos 8:148","journal-title":"Arch Osteoporos"},{"key":"585_CR9","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1007\/s11657-018-0542-5","volume":"13","author":"M Chandran","year":"2018","unstructured":"Chandran M, McCloskey EV, Thu WPP, Logan S, Hao Y, Tay D, Ang WC, Aung TKK, Choo KS, Ali A et al (2018) FRAX(R) based intervention thresholds for management of osteoporosis in Singaporean women. Arch Osteoporos 13:130","journal-title":"Arch Osteoporos"},{"key":"585_CR10","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.jocd.2013.06.002","volume":"17","author":"CH Wu","year":"2014","unstructured":"Wu CH, McCloskey EV, Lee JK, Itabashi A, Prince R, Yu W, Li-Yu J, Chionh SB, Zhao Y, Shin CS, Gunawan T, Tsai KS, Chieng PU, Changlai SP, Chan DC, Chen JF, Tanner SB, Hans DB, Kanis JA, Chang YF, Sun ZJ, Yang RS, Asia Pacific Panel of ISCD (2014) Consensus of official position of IOF\/ISCD FRAX initiatives in Asia-Pacific region. J Clin Densitom 17:150\u2013155","journal-title":"J Clin Densitom"},{"key":"585_CR11","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00198-016-3766-5","volume":"28","author":"M Chakhtoura","year":"2017","unstructured":"Chakhtoura M, Leslie WD, McClung M, Cheung AM, Fuleihan GE (2017) The FRAX-based Lebanese osteoporosis treatment guidelines: rationale for a hybrid model. Osteoporos Int 28:127\u2013137","journal-title":"Osteoporos Int"},{"key":"585_CR12","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s11657-016-0278-z","volume":"11","author":"JA Kanis","year":"2016","unstructured":"Kanis JA, Harvey NC, Cooper C, Johansson H, Oden A, McCloskey EV (2016) A systematic review of intervention thresholds based on FRAX : a report prepared for the National Osteoporosis Guideline Group and the International Osteoporosis Foundation. Arch Osteoporos 11:25","journal-title":"Arch Osteoporos"},{"key":"585_CR13","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","volume":"3","author":"WJ Youden","year":"1950","unstructured":"Youden WJ (1950) Index for rating diagnostic tests. Cancer 3:32\u201335","journal-title":"Cancer"},{"key":"585_CR14","unstructured":"Li C, Chen J, Qin G (2018) Partial Youden index and its inferences. J Biopharm Stat 1\u201315"},{"key":"585_CR15","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1007\/s10067-012-2106-1","volume":"32","author":"B Aubry-Rozier","year":"2013","unstructured":"Aubry-Rozier B, Stoll D, Krieg MA, Lamy O, Hans D (2013) What was your fracture risk evaluated by FRAX(R) the day before your osteoporotic fracture? Clin Rheumatol 32:219\u2013223","journal-title":"Clin Rheumatol"},{"key":"585_CR16","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s10067-014-2533-2","volume":"33","author":"XF Chen","year":"2014","unstructured":"Chen XF, Li XL, Zhang H, Liu GJ (2014) Were you identified to be at high fracture risk by FRAX(R) before your osteoporotic fracture occurred? Clin Rheumatol 33:693\u2013698","journal-title":"Clin Rheumatol"},{"key":"585_CR17","doi-asserted-by":"publisher","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","volume":"25","author":"F Cosman","year":"2014","unstructured":"Cosman F, de Beur SJ, LeBoff MS, Lewiecki EM, Tanner B, Randall S, Lindsay R (2014) Clinician\u2019s guide to prevention and treatment of osteoporosis. Osteoporos Int 25:2359\u20132381","journal-title":"Osteoporos Int"},{"key":"585_CR18","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.maturitas.2013.05.013","volume":"75","author":"J Compston","year":"2013","unstructured":"Compston J, Bowring C, Cooper A, Cooper C, Davies C, Francis R, Kanis JA, Marsh D, McCloskey EV, Reid DM, Selby P, National Osteoporosis Guideline Group (2013) Diagnosis and management of osteoporosis in postmenopausal women and older men in the UK: National Osteoporosis Guideline Group (NOGG) update 2013. Maturitas 75:392\u2013396","journal-title":"Maturitas"},{"key":"585_CR19","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.bone.2014.09.015","volume":"69","author":"JS Chen","year":"2014","unstructured":"Chen JS, Simpson JM, Blyth FM, March LM (2014) Managing osteoporosis with FRAX(R) in Australia: proposed new treatment thresholds from the 45&Up Study cohort. Bone 69:148\u2013153","journal-title":"Bone"},{"key":"585_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11657-012-0101-4","volume":"7","author":"S Tuzun","year":"2012","unstructured":"Tuzun S, Eskiyurt N, Akarirmak U, Saridogan M, Johansson H, McCloskey E, Kanis JA (2012) The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study. Arch Osteoporos 7:229\u2013235","journal-title":"Arch Osteoporos"},{"key":"585_CR21","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s00198-015-3176-0","volume":"26","author":"E McCloskey","year":"2015","unstructured":"McCloskey E, Kanis JA, Johansson H, Harvey N, Oden A, Cooper A, Cooper C, Francis RM, Reid DM, Marsh D et al (2015) FRAX-based assessment and intervention thresholds--an exploration of thresholds in women aged 50 years and older in the UK. Osteoporos Int 26:2091\u20132099","journal-title":"Osteoporos Int"},{"key":"585_CR22","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s00198-007-0544-4","volume":"19","author":"S Fujiwara","year":"2008","unstructured":"Fujiwara S, Nakamura T, Orimo H, Hosoi T, Gorai I, Oden A, Johansson H, Kanis JA (2008) Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int 19:429\u2013435","journal-title":"Osteoporos Int"},{"key":"585_CR23","first-page":"20","volume":"99","author":"J Compston","year":"2017","unstructured":"Compston J, Cooper C, Jiang X, Gruner M, Tremollieres F, Pluskiewicz W, Sornay-Rendu E, Adamczyk P, Schnatz PF (2017) Diagnostic accuracy of FRAX in predicting the 10-year risk of osteoporotic fractures using the USA treatment thresholds: a systematic review and meta-analysis. Osteoporos Int 99:20\u201325","journal-title":"Osteoporos Int"},{"key":"585_CR24","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jocd.2015.08.001","volume":"18","author":"G Kyriakos","year":"2015","unstructured":"Kyriakos G, Vidal-Casariego A, Fernandez-Martinez MN, Blanco-Suarez MD, Ballesteros-Pomar MD, Cano-Rodriguez I (2015) Impact of the NOGG and NOF guidelines on the indication of bone mineral density in routine clinical practice. J Clin Densitom 18:533\u2013538","journal-title":"J Clin Densitom"}],"container-title":["Archives of Osteoporosis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-019-0585-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11657-019-0585-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11657-019-0585-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,8]],"date-time":"2020-03-08T00:14:27Z","timestamp":1583626467000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11657-019-0585-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,9]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["585"],"URL":"https:\/\/doi.org\/10.1007\/s11657-019-0585-2","relation":{},"ISSN":["1862-3522","1862-3514"],"issn-type":[{"value":"1862-3522","type":"print"},{"value":"1862-3514","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,9]]},"assertion":[{"value":"30 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}}],"article-number":"33"}}